HR 6832 117th Congress House Health

To amend the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies, and from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID-19 pandemic.

Introduced: February 25, 2022 Introduced by: Cloud, Michael Republican · Texas See on congress.gov

Everywhere this bill has been 1 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Feb 28, 2022

Referred to the Subcommittee on Health.

What's happening now February 28, 2022

Referred to the Subcommittee on Health.

Cosponsors 5 matching